Contrast-Enhanced Ultrasound in Liver Cancer

References

• Bokor D , ChambersJB, ReesPJ, MantTG, LuzzaniF, SpinazziA. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest. Radiol.36(2), 104–109 (2001).
   PubMed Web of Science ®Google Scholar
• Torzilli G . Adverse effects associated with SonoVue use. Expert. Opin. Drug Saf.4(3), 399–401 (2005).
   PubMedGoogle Scholar
• Piscaglia F , BolondiL. Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med. Biol.32(9), 1369–1375 (2006).
   PubMed Web of Science ®Google Scholar
• Wei K , MulvaghSL, CarsonLet al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J. Am. Soc. Echocardiogr.21(11), 1202–1206 (2008).
   PubMed Web of Science ®Google Scholar
• Main ML , GoldmanJH, GrayburnPA. Ultrasound contrast agents: balancing safety versus efficacy. Expert. Opin. Drug Saf.8(1), 49–56 (2009).
   PubMed Web of Science ®Google Scholar
• Skyba DM , PriceRJ, LinkaAZ, SkalakTC, KaulS. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation98(4), 290–293 (1998).
   PubMed Web of Science ®Google Scholar
• Darge K , PapadopoulouF, NtouliaAet al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr. Radiol.43(9), 1063–1073 (2013).
   PubMed Web of Science ®Google Scholar
• Burrel M , LlovetJM, AyusoCet al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology38(4), 1034–1042 (2003).
   PubMed Web of Science ®Google Scholar
• Bhartia B , WardJ, GuthrieJA, RobinsonPJ. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am. J. Roentgenol.180(3), 577–584 (2003).
   PubMed Web of Science ®Google Scholar
• Leoni S , PiscagliaF, RighiniR, BolondiL. Management of small hepatocellular carcinoma. Acta. Gastroenterol. Belg.69(2), 230–235 (2006).
   PubMed Web of Science ®Google Scholar
• Dietrich CF , SharmaM, GibsonRN, Schreiber-DietrichD, JenssenC. Fortuitously discovered liver lesions. World J. Gastroenterol.19, 3173–3188 (2013).
   PubMed Web of Science ®Google Scholar
• Hirche TO , RusslerJ, SchröderOet al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand. J. Gastroenterol.37, 1178–1183 (2002).
   PubMed Web of Science ®Google Scholar
• Lencioni R , Della PinaC, CrocettiL, BozziE, CioniD. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US. Eur. Radiol.17, F73–F79 (2007).
   PubMed Web of Science ®Google Scholar
• Celli N , GaianiS, PiscagliaFet al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur. J. Gastroenterol. Hepatol.19(1), 3–14 (2007).
   PubMed Web of Science ®Google Scholar
• Sporea I , BadeaR, PopescuAet al. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med.35(3), 259–266 (2014).
   PubMed Web of Science ®Google Scholar
• Bruix J , ShermanM, LlovetJMet al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol.35, 421–430 (2001).
   PubMed Web of Science ®Google Scholar
• Bruix J , ShermanM. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology42, 1208–1236 (2005).
   PubMed Web of Science ®Google Scholar
• Bruix J , ShermanM. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology53, 1020–1022 (2011).
   PubMed Web of Science ®Google Scholar
• Italian Association for the Study of the Liver (AISF); AISF Expert Panel; AISF Coordinating Committee, BolondiL, CilloU, ColomboMet al.Position paper of the Italian Association for the Study of the Liver AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. Dig. Liver Dis.45(9), 712–723 (2013).
   PubMedGoogle Scholar
• Galassi M , IavaroneM, RossiSet al. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int.33(5), 771–779 (2013).
   PubMed Web of Science ®Google Scholar
• Vilana R , FornerA, BianchiLet al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology51, 2020–2029 (2010).
   PubMed Web of Science ®Google Scholar
• Li R , ZhangX, MaKSet al. Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis. Abdom. Imaging38, 112–119 (2013).
   PubMedGoogle Scholar
• Schima W , KulinnaC, LangenbergerH, Ba-SsalamahA. Liver metastases of colorectal cancer: US, CT or MR?Cancer Imaging5Spec No A, S149–S156 (2005).
   PubMedGoogle Scholar
• Page AJ , WeissMJ, PawlikTM. Surgical management of noncolorectal cancer liver metastases. Cancer120(20), 3111–3121 (2014).
   PubMed Web of Science ®Google Scholar
• Dietrich CF , KratzerW, StrobeDet al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J. Gastroenterol.12, 1699–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Claudon M , DietrichCF, ChoiBIet al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med.34(1), 11–29 (2013).
   PubMed Web of Science ®Google Scholar
• Alzaraa A , GravanteG, ChungWYet al. Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions. Hepatol. Res.43(8), 809–819 (2013).
   PubMed Web of Science ®Google Scholar
• Torzilli G , PalmisanoA, Del FabbroD. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience.Ann. Surg. Oncol.1347–1355 (2007).
   PubMed Web of Science ®Google Scholar
• Takahashi M , HasegawaK, AritaJet al. Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases. Br. J. Surg. 99(9), 1271–1277 (2012).
   PubMed Web of Science ®Google Scholar
• Shiozawa K , WatanabeM, KikuchiY, KudoT, MaruyamaK, SuminoY. Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study. World J. Gastroenterol.18(40), 5753–5758 (2012).
   PubMed Web of Science ®Google Scholar
• Yanagisawa K , MoriyasuF, MiyaharaT, YukiM, IijimaH. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med. Biol.33, 318–325 (2007).
   PubMed Web of Science ®Google Scholar
• Hatanaka K , KudoM, MinamiYet al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology51 (Suppl. 1), 61–69 (2008).
   PubMed Web of Science ®Google Scholar
• Martie A , BotaS, SporeaI, SirliR, PopescuA, DanilaM. The contribution of contrast enhanced ultrasound for the characterization of benign liver lesions in clinical practice – a monocentric experience. Med. Ultrason.14(4), 283–287 (2012).
   PubMed Web of Science ®Google Scholar
• Strobel D , BernatikT, BlankWet al. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med.32(6), 593–597 (2011).
   PubMed Web of Science ®Google Scholar
• Claudon M , CosgroveD, AlbrechtTet al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med.29, 28–44 (2008).
   PubMed Web of Science ®Google Scholar
• Nordenstedt H , WhiteDL, El-SeragHB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis.42 (Suppl. 3), S206–S214 (2010).
   PubMedGoogle Scholar
• Kudo M , IzumiN, KokudoNet al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig. Dis.29, 339–364 (2011).
   PubMed Web of Science ®Google Scholar
• Leoni S , PiscagliaF, GranitoAet al. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? Ultraschall Med. 34(3), 280–287 (2013).
   PubMed Web of Science ®Google Scholar
• Bolondi L , GaianiS, CelliNet al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology42(1), 27–34 (2005).
   PubMed Web of Science ®Google Scholar
• Forner A , VilanaR, AyusoCet al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology47(1), 97–104 (2008).
   PubMed Web of Science ®Google Scholar
• Sangiovanni A , ManiniMA, IavaroneMet al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut59, 638–644 (2010).
   PubMed Web of Science ®Google Scholar
• Di Martino M , De FilippisG, De SantisAet al. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. Eur. Radiol.23(4), 887–896 (2013).
   PubMed Web of Science ®Google Scholar
• Mita K , KimSR, KudoMet al. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. World J. Gastroenterol.16(33), 4187–4192 (2010).
   PubMed Web of Science ®Google Scholar
• Leoni S , PiscagliaF, GolfieriRet al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am. J. Gastroenterol.105(3), 599–609 (2010).
   PubMed Web of Science ®Google Scholar
• Boozari B , SoudahB, RifaiKet al. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study. Dig. Liver Dis.43(6), 484–490 (2011).
   PubMedGoogle Scholar
• Fan ZH , ChenMH, DaiYet al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am. J. Roentgenol.186(6), 1512–1519 (2006).
   PubMed Web of Science ®Google Scholar
• Rimola J , FornerA, ReigMet al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology50(3), 791–798 (2009).
   PubMed Web of Science ®Google Scholar
• Xu HX , ChenLD, LiuLN, ZhangYF, GuoLH, LiuC. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Br. J. Radiol.85, 1029–1037 (2012).
   PubMed Web of Science ®Google Scholar
• Chung YE , KimMJ, ParkYNet al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics29, 683–700 (2009).
   PubMed Web of Science ®Google Scholar
• Dietrich CF , KratzerW, StrobeDet al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J. Gastroenterol.12, 1699–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Albrecht T , OldenburgA, HohmannJet al. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur. Radiol.13, N79–N86 (2003).
   PubMed Web of Science ®Google Scholar
• Bhayana D , KimTK, JangHJet al. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am. J. Roentdenol.194(4), 977–983 (2010).
   PubMed Web of Science ®Google Scholar
• Kong WT , WangWP, HuangBJ, DingH, MaoF. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound. J. Gastroenterol. Hepatol.29(3), 576–580 (2014).
   PubMed Web of Science ®Google Scholar